And with Novo Nordisk quietly doubling down on GLP-1 innovation, its hard not to wonder if this study hints at their next move
Secondary outcomes included all-cause mortality, cardiovascular mortality, hospitalisation for heart failure, a kidney composite endpoint and serious adverse events
As with all prescription medications, long-term safety requires ongoing monitoring, especially when used alongside other medicines or for off-label weight loss treatment
DOI: 10.3390/cells10102759 [Google Scholar] Kisseleva T, Brenner D
this masks the green taste even further and reduces how noticeable the Stevia is
Dulaglutide is a long-acting GLP-1 RA consisting of two identical disulfide-linked chains, each containing a GLP-1 analog covalently fused to the Fc fragment of a modified human immunoglobulin G4 (IgG4)